CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 95 enrolled
Drug / intervention
BRCA-Gistbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03511690
NCT03511690N/ACompleted
CompareCT.gov

Testing an Intelligent Tutoring System Intervention to Enhance Genetic Risk Assessment in Underserved Blacks and Latinas at Risk of Hereditary Breast Cancer

Georgetown University·interventional·Posted Apr 30, 2018·Updated Apr 25, 2022

In Brief

A clinical study evaluating BRCA-Gist for Hereditary Breast and Ovarian Cancer. Completed, enrolled 95 participants across 4 sites.

Detailed Summary

Participating in genetic cancer risk assessments (GCRA) for hereditary breast and ovarian cancer can inform treatment and risk management decisions and improve breast cancer outcomes. However, Latina and Black women underuse GCRA services, which may increase breast cancer disparities. This study will adapt and test the impact of an easily scalable novel Tutoring System intervention to enhance GCRA use and improve psychosocial outcomes in a clinical sample of underserved Latina and Black women at risk of hereditary breast and ovarian cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHereditary Breast and Ovarian Cancer
CountriesUnited States
CollaboratorsVirginia Commonwealth University, Cornell University

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 30, 2018
Enrollment StartJul 1, 2017
Primary CompletionFeb 20, 2022
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 8.2 years ago

Interventions

BRCA-Gistbehavioral

BRCA-gist is an innovative Intelligent Tutoring System intervention that uses avatars to emulate tailored one-to-one human tutoring and includes the bottom-line meaning of risk messages. BRCA-gist is designed to provide the same information contained in four modules from the NCI webpages: "breast cancer and metastasis," "risk factors," "genetic mutation testing," and "the consequences of testing.